These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 35398234)

  • 1. Muscle-specific programmed cell death 5 in heart disease: Friend or foe?
    Mu L; Li L; Liu W
    Int J Cardiol; 2022 Jun; 356():87. PubMed ID: 35398234
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to: Muscle-specific programmed cell death 5 in heart disease: Friend or foe?
    Zhu H; He L
    Int J Cardiol; 2022 Nov; 366():70. PubMed ID: 35817201
    [No Abstract]   [Full Text] [Related]  

  • 3. Brg1 in heart disease: Friend or foe?
    Zhang X; Xia Y; Wang B
    Int J Cardiol; 2022 Feb; 348():116. PubMed ID: 34856298
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to Wagner et al.: phosphodiesterase-2-anti-adrenergic friend or hypertrophic foe in heart disease?
    Zoccarato A; Fields LH; Zaccolo M
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1143-1145. PubMed ID: 27678409
    [No Abstract]   [Full Text] [Related]  

  • 5. [High sensitivity cardiac troponin T - friend or foe?].
    Arnar DO
    Laeknabladid; 2012 Jan; 98(1):9. PubMed ID: 22253085
    [No Abstract]   [Full Text] [Related]  

  • 6. Immediate early gene expression in response to cerebral ischemia. Friend or foe?
    Akins PT; Liu PK; Hsu CY
    Stroke; 1996 Sep; 27(9):1682-7. PubMed ID: 8784149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endurance Exercise and the Heart: Friend or Foe?
    Sanchis-Gomar F; Pérez LM; Joyner MJ; Löllgen H; Lucia A
    Sports Med; 2016 Apr; 46(4):459-66. PubMed ID: 26586557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na(+)-Ca(2+) exchange in failing myocardium: friend or foe?
    Barry WH
    Circ Res; 2000 Sep; 87(7):529-31. PubMed ID: 11009553
    [No Abstract]   [Full Text] [Related]  

  • 9. Programmed necrosis in heart disease: Molecular mechanisms and clinical implications.
    Zhu H; Sun A
    J Mol Cell Cardiol; 2018 Mar; 116():125-134. PubMed ID: 29426003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy in neurodegenerative disease: friend, foe or turncoat?
    Nixon RA
    Trends Neurosci; 2006 Sep; 29(9):528-35. PubMed ID: 16859759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial, temporal and hormonal regulation of programmed muscle cell death during metamorphosis of the frog Xenopus laevis.
    Nishikawa A; Hayashi H
    Differentiation; 1995 Nov; 59(4):207-14. PubMed ID: 8575642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR ligands and cardiovascular disorders: friend or foe.
    Balakumar P; Jagadeesh G
    Curr Mol Pharmacol; 2012 Jun; 5(2):219-23. PubMed ID: 22122451
    [No Abstract]   [Full Text] [Related]  

  • 13. [Microbial "friend-foe" identification in human intestine microsymbiocenosis].
    Bukharin OV; Petrunova NB
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):46-51. PubMed ID: 22308727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulators of apoptosis in the heart: a matter of life and death.
    Kirshenbaum LA
    Can J Cardiol; 1998 Mar; 14(3):457-60. PubMed ID: 9551035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FRIEND or FOE: A prospective evaluation of risk factors for reintubation in surgical and trauma patients.
    Michetti CP; Griffen MM; Teicher EJ; Rodriguez JL; Seoudi H; Liu C; Lita E; Newcomb A
    Am J Surg; 2018 Dec; 216(6):1056-1062. PubMed ID: 30017306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mind-muscle connection in resistance training: friend or foe?
    Halperin I; Vigotsky AD
    Eur J Appl Physiol; 2016 Apr; 116(4):863-4. PubMed ID: 26896956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular senescence in cancer treatment: friend or foe?
    Kahlem P; Dörken B; Schmitt CA
    J Clin Invest; 2004 Jan; 113(2):169-74. PubMed ID: 14722606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed cell death in the developing heart: regulation by BMP4 and FGF2.
    Zhao Z; Rivkees SA
    Dev Dyn; 2000 Apr; 217(4):388-400. PubMed ID: 10767083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From friend to foe: Pro-apoptotic action of nuclear ARC in diabetes.
    Onodera T; Scherer PE
    Dev Cell; 2021 Mar; 56(6):717-718. PubMed ID: 33756115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dinucleoside polyphosphates-friend or foe?
    McLennan AG
    Pharmacol Ther; 2000; 87(2-3):73-89. PubMed ID: 11007992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.